Construction and characterization of porcine single-chain fragment variable antibodies that neutralize transmissible gastroenteritis virus in vitro
- 7 Downloads
Transmissible gastroenteritis virus (TGEV) infection causes severe diarrhea in piglets and imposes a significant economic burden on pig farms. Single-chain fragment variable (scFv) antibodies effectively inhibit virus infection and could be a potential therapeutic reagent for preventing disease. In this study, a recombinant scFv antibody phage display library was constructed from peripheral blood lymphocytes of piglets infected with TGEV. The library was screened with four rounds of biopanning using purified TGEV antigen, and scFv antibodies that bound to TGEV were obtained. The scFv gene was subcloned into the pET-28a(+), and the constituted plasmid was introduced into Escherichia coli BL21 (DE3) for protein expression. All three scFv clones identified had neutralizing activity against TGEV. An immunofluorescence assay and western blot analysis demonstrated that two scFv antibodies reacted with the spike protein of TGEV. These results indicate that scFv antibodies provide protection against viral infection in vitro and may be a therapeutic candidate for both prevention and treatment of TGEV infection in swine.
This work was financially supported by the Key Project of Science and Technology for Agriculture of Shanghai (Hu Nong Ke Gong Zi (2015) no. 1-8).
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
The animal experiment was performed in accordance with the recommendations in the Guidelines for the Use of Laboratory Animals provided by the Science and Technology Commission of Shanghai Municipality (STCSM). The protocol was approved by the ethics committee of the Shanghai JiaoTong University, School of Agriculture and Biology.
- 3.Schwegmann-Wessels C, Herrler G (2006) Transmissible gastroenteritis virus infection: a vanishing specter. Dtsch Tierarztl Wochenschr 113:157–159Google Scholar
- 5.Laude H, Van Reeth K, Pensaert M (1993) Porcine respiratory coronavirus: molecular features and virus-host interactions. Vet Res 24:125–150Google Scholar
- 6.Krempl C, Schultze B, Laude H, Herrler G (1997) Point mutations in the S protein connect the sialic acid binding activity with the enteropathogenicity of transmissible gastroenteritis coronavirus. J Virol 71:3285–3287Google Scholar
- 8.Delmas B, Rasschaert D, Godet M, Gelfi J, Laude H (1990) Four major antigenic sites of the coronavirus transmissible gastroenteritis virus are located on the amino-terminal half of spike glycoprotein S. J Gen Virol 71(Pt 6):1313–1323. https://doi.org/10.1099/0022-1317-71-6-1313 CrossRefGoogle Scholar
- 11.Meng F, Ren Y, Suo S, Sun X, Li X, Li P, Yang W, Li G, Li L, Schwegmann-Wessels C, Herrler G, Ren X (2013) Evaluation on the efficacy and immunogenicity of recombinant DNA plasmids expressing spike genes from porcine transmissible gastroenteritis virus and porcine epidemic diarrhea virus. PLoS One 8:e57468CrossRefGoogle Scholar
- 14.Bohl EH, Gupta RK, Olquin MV, Saif LJ (1972) Antibody responses in serum, colostrum, and milk of swine after infection or vaccination with transmissible gastroenteritis virus. Infect Immun 6:289–301Google Scholar
- 15.Wesley RD, Woods RD (2001) Partial passive protection with two monoclonal antibodies and frequency of feeding of hyperimmune anti-transmissible gastroenteritis virus (TGEV) serum for protection of three-day-old piglets from a TGEV challenge infection. J Vet Diagn Investig 13:290–296. https://doi.org/10.1177/104063870101300402 CrossRefGoogle Scholar
- 16.Bestagno M, Sola I, Dallegno E, Sabella P, Poggianella M, Plana-Duran J, Enjuanes L, Burrone OR (2007) Recombinant dimeric small immunoproteins neutralize transmissible gastroenteritis virus infectivity efficiently in vitro and confer passive immunity in vivo. J Gen Virol 88:187–195. https://doi.org/10.1099/vir.0.82192-0 CrossRefGoogle Scholar
- 20.Chai Z, Fu F, Jiang F, Tian H, Wang Z, Zheng N, Zhang X, Wang X, Li X (2014) Development of a neutralizing mouse-pig chimeric antibody with therapeutic potential against Haemophilus parasuis in Pichia pastoris. FEMS Microbiol Lett 354:85–91. https://doi.org/10.1111/1574-6968.12437 CrossRefGoogle Scholar
- 21.Corti D, Voss J, Gamblin SJ, Codoni G, Macagno A, Jarrossay D, Vachieri SG, Pinna D, Minola A, Vanzetta F, Silacci C, Fernandez-Rodriguez BM, Agatic G, Bianchi S, Giacchetto-Sasselli I, Calder L, Sallusto F, Collins P, Haire LF, Temperton N, Langedijk JP, Skehel JJ, Lanzavecchia A (2011) A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins. Science 333:850–856. https://doi.org/10.1126/science.1205669 CrossRefGoogle Scholar
- 23.Schofield DJ, Pope AR, Clementel V, Buckell J, Chapple S, Clarke KF, Conquer JS, Crofts AM, Crowther SR, Dyson MR, Flack G, Griffin GJ, Hooks Y, Howat WJ, Kolb-Kokocinski A, Kunze S, Martin CD, Maslen GL, Mitchell JN, O’Sullivan M, Perera RL, Roake W, Shadbolt SP, Vincent KJ, Warford A, Wilson WE, Xie J, Young JL, McCafferty J (2007) Application of phage display to high throughput antibody generation and characterization. Genome Biol 8:R254CrossRefGoogle Scholar
- 24.Yokota T, Milenic DE, Whitlow M, Schlom J (1992) Rapid tumor penetration of a single-chain Fv and comparison with other immunoglobulin forms. Cancer Res 52:3402–3408Google Scholar
- 26.Liu H, Wang Y, Duan H, Zhang A, Liang C, Gao J, Zhang C, Huang B, Li Q, Li N, Xiao S, Zhou EM (2015) An intracellularly expressed Nsp9-specific nanobody in MARC-145 cells inhibits porcine reproductive and respiratory syndrome virus replication. Vet Microbiol 181:252–260. https://doi.org/10.1016/j.vetmic.2015.10.021 CrossRefGoogle Scholar
- 34.Lee DH, Jeon YS, Park CK, Kim S, Lee DS, Lee C (2015) Immunoprophylactic effect of chicken egg yolk antibody (IgY) against a recombinant S1 domain of the porcine epidemic diarrhea virus spike protein in piglets. Arch Virol 160:2197–2207. https://doi.org/10.1007/s00705-015-2494-z CrossRefGoogle Scholar
- 35.Garaicoechea L, Olichon A, Marcoppido G, Wigdorovitz A, Mozgovoj M, Saif L, Surrey T, Parreno V (2008) Llama-derived single-chain antibody fragments directed to rotavirus VP6 protein possess broad neutralizing activity in vitro and confer protection against diarrhea in mice. J Virol 82:9753–9764CrossRefGoogle Scholar
- 43.Yang J, Yoshida R, Kariya Y, Zhang X, Hashiguchi S, Nakashima T, Suda Y, Takada A, Ito Y, Sugimura K (2010) Characterization of human single-chain antibodies against highly pathogenic avian influenza H5N1 viruses: mimotope and neutralizing activity. J Biochem 148:507–515. https://doi.org/10.1093/jb/mvq084 Google Scholar
- 44.Khan L, Kumar R, Thiruvengadam R, Parray HA, Makhdoomi MA, Kumar S, Aggarwal H, Mohata M, Hussain AW, Das R, Varadarajan R, Bhattacharya J, Vajpayee M, Murugavel KG, Solomon S, Sinha S, Luthra K (2017) Cross-neutralizing anti-HIV-1 human single chain variable fragments(scFvs) against CD4 binding site and N332 glycan identified from a recombinant phage library. Sci Rep 7:45163CrossRefGoogle Scholar
- 48.Jacobs L, van der Zeijst BA, Horzinek MC (1986) Characterization and translation of transmissible gastroenteritis virus mRNAs. J Virol 57:1010–1015Google Scholar
- 50.Zhang D, Huang X, Zhang X, Cao S, Wen X, Wen Y, Wu R, Liang E (2016) Construction of an oral vaccine for transmissible gastroenteritis virus based on the TGEV N gene expressed in an attenuated Salmonella typhimurium vector. J Virol Methods 227:6–13. https://doi.org/10.1016/j.jviromet.2015.08.011 CrossRefGoogle Scholar